First Assessment in Humans of the Safety, Tolerability, Pharmacokinetics, and Ex Vivo Pharmacodynamic Antimalarial Activity of the New Artemisinin Derivative Artemisone

Antimicrobial Agents and Chemotherapy- United States

doi 10.1128/aac.01585-07

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society for Microbiology

Related search

P200 Development of New Antimalarial Drugs : In Vitro and in Vivo Antimalarial Activity of Endoperoxides

Medical Entomology and Zoology
2001English

In Vivo Pharmacodynamic Activity of the Glycopeptide Dalbavancin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2007English

Reaction of Artemisinin With Haemoglobin: Implications for Antimalarial Activity

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2005English

Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2009English

Safety, Tolerability, Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Modelling of the Novel H4 Receptor Inhibitor SENS-111 Using a Modified Caloric Test in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2018English

Comparison of the Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Healthy Japanese and Caucasian Subjects

Clinical Drug Investigation
MedicinePharmacology
2015English

Efficacy and Safety of Artemisinin-Based Antimalarial in the Treatment of Uncomplicated Malaria in Children in Southern Tanzania

Malaria Journal
ParasitologyInfectious Diseases
2007English

Drug Resistance Genomics of the Antimalarial Drug Artemisinin

Genome Biology
2014English

Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-In-Human Study of a Novel Antimalarial Drug

Malaria Research and Treatment
EpidemiologyInfectious Diseases
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy